Data collection infrastructure for patient outcomes in the UK - opportunities and challenges for cell and gene therapies launching
{{output}}
Background: Cell and gene therapies are associated with uncertainty around their value claims at launch due to limitations of supporting clinical data; furthermore, their high costs present affordability issues for payers. Outcomes-based reimbursement can redu... ...
